Hematology and Cardio-Oncology

Hematology and Cardio-OncologyCardiovascular problems via blood and therefore the system that gives laboratory values regarding blood, the circulatory system and secures cardiovascular diseases from the Chinese medicine and western medicine perspectives.

Cardio-Oncology is to seek out a balance between oncologic efficacy and reducing antagonistic cardiovascular effects over timely publication and broadcasting of research. Cardiac imaging and transthoracic echocardiography play an important role within the baseline assessment and serial follow-up of cardio-oncology patients. Scientific indication in the administration of cardiovascular hitches of onco-hematological patients is unusual, as these patients have been systematically omitted from clinical trials and up-to-date approvals are based on expert consent. Cardio-onco-hematology which permit its claim in regular clinical preparation so to market the expansion of local multidisciplinary crews, to rally the cardiovascular health of patients with cancer.

  • Amyloid cardiomyopathy
  • Echocardiographic
  • Cardiotoxicity
  • Chemotherapy
  • Cancer Genomics

Related Conference of Hematology and Cardio-Oncology

January 24-25, 2022

2nd European Congress on Hematology

Prague, Czech Republic
January 27-28, 2022

2nd World Congress on Hematology and Genetic Blood Disorders

Prague, Czech Republic
March 14-15, 2022

20th World Hematology Congress

London, UK

Hematology and Cardio-Oncology Conference Speakers

Recommended Sessions

Related Journals

Are you interested in